CNR2 and neoplasm: Studies have shown that in HER2 positive breast cancer cells, the use of cannabinoids, such as Δ-9-THC or JWH133, a synthetic CB2 specific agonist, can reduce the progression of the disease by a decrease in the tumour number, growth and metastases (120).